Healthcare & Life Sciences

Healthcare M&A is about advancing lives through innovation and care. At Aquisita, we facilitate partnerships that enhance patient outcomes and drive sector evolution.

We provide M&A advisory to clients in the healthcare and life sciences sectors, focusing on strategic acquisitions of biotech, pharmaceutical, and medical device companies. Recent deal activity includes acquisitions in gene therapy, digital health platforms, and telemedicine services. Aquisita identifies high-value opportunities in emerging sectors, such as personalized medicine and health-tech innovations, helping clients expand their capabilities and market share.

Sector expertise

How We Help Clients

Here’s a refined list of key areas in the Healthcare and Life Sciences sector, highlighting where M&A can add value or be involved:

Pharmaceuticals

Acquiring pharmaceutical companies or product pipelines can accelerate market entry, expand portfolios, and strengthen R&D capabilities for new drugs and vaccines.

Biotechnology

M&A with biotech firms can foster innovation in cutting-edge areas like genetic engineering, cell therapy, and biopharmaceuticals, enabling faster development and commercialization.

Medical Devices and Equipment

Acquiring device manufacturers or tech startups can enhance offerings in diagnostics, wearable technologies, and advanced surgical instruments.

Healthcare Services

Consolidation of hospitals, clinics, or specialty care facilities can improve patient access, operational efficiency, and geographic presence.

Telemedicine and Digital Health

Strategic acquisitions of telehealth platforms or digital health apps can expand remote healthcare capabilities, patient engagement, and data-driven care delivery.

Diagnostics and Laboratory Services

M&A in diagnostics companies or lab networks can increase access to advanced testing services, expand geographical reach, and optimize R&D capabilities.

Contract Research and Manufacturing Organizations (CROs/CMOs)

Acquiring CROs or CMOs can streamline clinical trials, scale manufacturing operations, and reduce time-to-market for new therapies.

Health Insurance and Financing

M&A in health insurance providers or insurtech firms can diversify offerings, enhance risk management, and optimize customer acquisition channels.

Nutraceuticals and Functional Foods

Acquiring nutraceutical companies or brands can address growing consumer demand for health supplements and preventive healthcare solutions.

Regenerative Medicine and Advanced Therapies

M&A in regenerative medicine firms or advanced therapy startups can accelerate innovation in stem cell therapy, tissue engineering, and gene editing technologies.

Collaborate with Us!

From scaling startups to optimizing established businesses, Aquisita delivers proven results and long-term value.